The results showed that USP10 expression in breast cancer, cervical cancer, colorectal cancer, gastric cancer, head and neck cancer, leukemia, lung cancer, lymphoma, melanoma, myeloma, and prostate cancer was higher than that in normal tissues (Figure 1A). This evidence concerns the gene USP10 and prostate carcinoma.